Bank of New York Mellon Corp - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$2,048,696
-18.3%
375,908
+0.6%
0.00%
-100.0%
Q2 2023$2,506,738
-25.5%
373,583
-2.0%
0.00%0.0%
Q1 2023$3,366,054
+12.5%
381,207
-2.6%
0.00%0.0%
Q4 2022$2,991,538
+5.5%
391,563
-1.7%
0.00%0.0%
Q3 2022$2,836,000
-7.6%
398,331
+5.0%
0.00%0.0%
Q2 2022$3,070,000
-75.6%
379,434
-58.1%
0.00%
-50.0%
Q1 2022$12,572,000
-51.8%
905,769
-2.5%
0.00%
-60.0%
Q4 2021$26,074,000
-17.6%
929,187
-0.2%
0.01%
-16.7%
Q3 2021$31,657,000
-14.4%
931,372
+2.9%
0.01%
-14.3%
Q2 2021$36,998,000
+5.4%
905,503
+3.9%
0.01%0.0%
Q1 2021$35,090,000
-31.6%
871,575
+0.5%
0.01%
-36.4%
Q4 2020$51,298,000
+34.6%
867,533
+10.7%
0.01%
+22.2%
Q3 2020$38,107,000
+11.5%
783,617
+10.9%
0.01%0.0%
Q2 2020$34,172,000
+753.2%
706,335
+389.9%
0.01%
+800.0%
Q1 2020$4,005,000
+216.4%
144,165
+240.7%
0.00%
Q4 2019$1,266,000
+33.4%
42,316
+37.8%
0.00%
Q3 2019$949,00030,7100.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders